| scholarly article | Q13442814 |
| P50 | author | Joseph C. Wu | Q59749300 |
| P2093 | author name string | Nigel G Kooreman | |
| P2860 | cites work | Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Q21090134 |
| Control of apoptosis and mitotic spindle checkpoint by survivin | Q22008570 | ||
| A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 | ||
| Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction | Q24534652 | ||
| Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma | Q24598366 | ||
| Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells | Q24616059 | ||
| Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine | Q24646217 | ||
| In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery | Q27339181 | ||
| Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes | Q27438164 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Generation of germline-competent induced pluripotent stem cells | Q28131699 | ||
| Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells | Q28269087 | ||
| Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. | Q45866856 | ||
| Molecular imaging of human embryonic stem cells: keeping an eye on differentiation, tumorigenicity and immunogenicity | Q46106191 | ||
| Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t. | Q46168827 | ||
| Fate of embryonic stem cell derivatives implanted into the vitreous of a slow retinal degenerative mouse model | Q46622264 | ||
| Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells | Q48876988 | ||
| Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. | Q48987592 | ||
| In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction | Q50765152 | ||
| The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. | Q51791870 | ||
| Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. | Q53453905 | ||
| Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. | Q53526425 | ||
| Long-term multiple color imaging of live cells using quantum dot bioconjugates | Q62108902 | ||
| Origin of testicular teratomas from primordial germ cells in mice | Q72220143 | ||
| The development of teratomas from intratesticular grafts of tubal mouse eggs | Q72235355 | ||
| A description of spontaneous congenital testicular teratomas in strain 129 mice | Q74786531 | ||
| In vivo imaging of quantum dots encapsulated in phospholipid micelles | Q78594973 | ||
| Teratocarcinogenic and tissue-forming potentials of the cell types comprising neoplastic embryoid bodies | Q78972246 | ||
| Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant transformation | Q80760352 | ||
| Viable offspring derived from fetal and adult mammalian cells | Q28304072 | ||
| An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors | Q29615393 | ||
| Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells | Q29616179 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases | Q29622846 | ||
| Monitoring of bone marrow cell homing into the infarcted human myocardium | Q31162853 | ||
| Testicular germ-cell tumours in a broader perspective. | Q33212387 | ||
| Quantum dot imaging for embryonic stem cells | Q33302075 | ||
| Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter | Q33643871 | ||
| Mutational derivatives of PhiC31 integrase with increased efficiency and specificity | Q33713025 | ||
| Effects of cell number on teratoma formation by human embryonic stem cells | Q33835956 | ||
| Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation | Q33836004 | ||
| iPS cells produce viable mice through tetraploid complementation | Q34018898 | ||
| Promotion of direct reprogramming by transformation-deficient Myc. | Q34069504 | ||
| MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS | Q34258545 | ||
| EXPERIMENTAL PRODUCTION OF TESTICULAR TERATOMAS IN MICE | Q34411978 | ||
| Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues | Q34417194 | ||
| Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. | Q34462411 | ||
| Effects of long-term culture on human embryonic stem cell aging. | Q34485779 | ||
| Molecular-genetic imaging: current and future perspectives | Q35019503 | ||
| Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells | Q35672517 | ||
| Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability | Q35828731 | ||
| Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects | Q36800094 | ||
| Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function | Q36853977 | ||
| Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults. | Q36897184 | ||
| Proteomic analysis of reporter genes for molecular imaging of transplanted embryonic stem cells | Q36931675 | ||
| Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors | Q37089250 | ||
| The tumorigenicity of human embryonic stem cells | Q37213616 | ||
| Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats | Q37255180 | ||
| Myc's broad reach | Q37299032 | ||
| The tumorigenicity of diploid and aneuploid human pluripotent stem cells | Q37627079 | ||
| Generation of platform human embryonic stem cell lines that allow efficient targeting at a predetermined genomic location. | Q39862819 | ||
| Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma | Q39966384 | ||
| Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 | ||
| Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation | Q40334464 | ||
| Cardiac reporter gene imaging using the human sodium/iodide symporter gene. | Q40458403 | ||
| Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells | Q40544422 | ||
| Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture | Q40843384 | ||
| Embryonal stem cells do not undergo cell cycle arrest upon exposure to damaging factors | Q44231935 | ||
| Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals | Q45862535 | ||
| P921 | main subject | pluripotency | Q1894941 |
| P304 | page(s) | S753-63 | |
| P577 | publication date | 2010-09-29 | |
| P1433 | published in | Journal of the Royal Society Interface | Q2492390 |
| P1476 | title | Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging | |
| P478 | volume | 7 Suppl 6 |
| Q40059071 | Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions. |
| Q49886571 | Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo |
| Q38239661 | Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? |
| Q39031369 | Cell-Based Biohybrid Drug Delivery Systems: The Best of the Synthetic and Natural Worlds |
| Q38141509 | Cellular reprogramming of human peripheral blood cells |
| Q37997154 | Current applications of human pluripotent stem cells: possibilities and challenges |
| Q39262859 | Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice. |
| Q37990325 | Development of pluripotent stem cells for vascular therapy |
| Q34466816 | Embryonic stem cell-derived M2-like macrophages delay cutaneous wound healing |
| Q34239856 | Empowering adult stem cells for myocardial regeneration |
| Q58754595 | FACT Sets a Barrier for Cell Fate Reprogramming in Caenorhabditis elegans and Human Cells |
| Q36065349 | Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes |
| Q36531665 | Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues. |
| Q37917591 | Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation. |
| Q36666422 | Immunological applications of stem cells in type 1 diabetes |
| Q49160861 | In vitro modelling of cortical neurogenesis by sequential induction of human umbilical cord blood stem cells |
| Q92436206 | In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation |
| Q38205724 | Is regenerative medicine a new hope for kidney replacement? |
| Q82906462 | Making the case for private cord blood banking: mission accomplished!: comment to Schmidt et al., Stem Cell Rev and Rep (2010) 6:234-236 |
| Q38124756 | Mechanistic molecular imaging of cardiac cell therapy for ischemic heart disease |
| Q63431938 | Minimally Invasive and Regenerative Therapeutics |
| Q38003151 | Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity |
| Q37711057 | Multiplexing SERS nanotags for the imaging of differentiated mouse embryonic stem cells (mESC) and detection of teratoma in vivo |
| Q38048838 | New cell therapies in cardiology. |
| Q37243068 | Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation |
| Q41836711 | Patient-specific pluripotent stem cells in neurological diseases |
| Q28088720 | Plasticity of spermatogonial stem cells |
| Q33909634 | Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration |
| Q28533971 | SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance |
| Q33920686 | Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Plurip |
| Q55514058 | Sheep embryonic stem-like cells engrafted into sheep femoral condyle osteochondral defects: 4-year follow-up. |
| Q37976119 | Standardization of pluripotent stem cell cultures for toxicity testing |
| Q28069506 | Stem Cell Therapy: A Prospective Treatment for Alzheimer's Disease |
| Q38106714 | Stem cell-based bone repair |
| Q42137997 | Stem cells as a tool for breast imaging |
| Q38124263 | Stem cells for cardiac repair: an introduction |
| Q37938917 | Stem cells for retinal replacement therapy |
| Q38479106 | Stem cells for the cell and molecular therapy of type 1 diabetes mellitus (T1D): the gap between dream and reality |
| Q37844455 | Stem cells in tooth tissue regeneration--challenges and limitations |
| Q33653485 | Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy |
| Q37347017 | Suicide Gene Therapy for Cancer - Current Strategies |
| Q34964650 | Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine |
| Q38040207 | Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. |
| Q35471418 | Teratoma formation: a tool for monitoring pluripotency in stem cell research |
| Q36076059 | Teratoma showing the features of retinal structure: A case of sacrococcygeal teratoma |
| Q38180960 | Tracking gene and cell fate for therapeutic gain |
| Q42350843 | Translation and commercialization of regenerative medicines |
Search more.